NC
IRMD icon

Northpointe Capital’s iRadimed IRMD Stock Holding History

Northpointe Capital’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-60,275
Closed -$918K – 214
2015
Q1 		$918K Buy
60,275
+13,715
+29% +$203K 0.1% 213
2014
Q4 		$601K Buy
+46,560
New +$402K 0.07% 217

Other funds holding IRMD

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northpointe Capital's IRMD Position: Q2 2015 in Review

Northpointe Capital sold out of iRadimed (IRMD) in Q2 2015, closing a stake of 60,275 shares — an estimated $918K sold.

Northpointe Capital first reported a position in IRMD in Q4 2014 and held it in 2 quarters. The position peaked at $918K in Q1 2015. 39 funds tracked by Wall St. Rank hold IRMD as of Q2 2015.

  • Northpointe Capital reported no remaining iRadimed position as of Q2 2015 after selling out during the quarter.
  • Northpointe Capital sold 60,275 iRadimed shares in Q2 2015, an estimated $918K.
  • Northpointe Capital first reported a position in iRadimed in Q4 2014 and held it in 2 quarters.
  • Northpointe Capital's iRadimed position peaked at $918K in Q1 2015.
  • 39 funds tracked by Wall St. Rank held iRadimed as of Q2 2015.

Based on Northpointe Capital's 13F filing for Q2 2015, filed 30 Jul 2015.